InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR)

CUSIP: 45779A846

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 6 signals
Share change
+450,470
SEC-reported price per share
$2.68
Number of holders
27
Value change
+$1,209,473
Number of buys
8
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,244,715

Security key

45779A846

Report period

Q3 2024

Institutions

27

Top holders

10

Ownership snapshot

Top reported holders of NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F 3/4/5 Highest disclosed value: $6,272,288 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Rosalind Advisors, Inc. has the largest disclosed position value at $6.27M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rosalind Advisors, Inc.'s linked filing trail.
Disclosed position value Top 5
Rosalind Advisors, Inc. $6.27M
ORBIMED ADVISORS LLC $5.32M
Nantahala Capital Management, LLC $5.06M
MARSHALL WACE, LLP $4.67M
Soleus Capital Management, L.P. $3.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rosalind Advisors, Inc.
13F
Company
13F
—
denominator unverified
$6,272,288
2,513,641 shares
— 30 Jun 2024
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$5,323,485
2,133,405 shares
— 30 Jun 2024
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$5,056,975
2,026,600 shares
— 30 Jun 2024
MARSHALL WACE, LLP
13F
Company
13F
—
denominator unverified
$4,669,617
1,860,405 shares
— 30 Jun 2024
Soleus Capital Management, L.P.
13F
Company
13F
—
denominator unverified
$3,438,843
1,378,128 shares
— 30 Jun 2024
Velan Capital Investment Management LP
13F
Company
13F
—
denominator unverified
$2,255,824
904,029 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
27
Shares
12,402,374
Rows available
27
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q1 2026 Across Filers

Q1 2026 holders
34
Q3 2024 holders
27
Holder diff
-7
Investor Q1 2026 Shares Q3 2024 Shares Share Diff Share Chg % Q1 2026 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .